AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ebner, F
Right arrow Articles by Justich, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ebner, F
Right arrow Articles by Justich, E
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 153, Issue 6, 1283-1288
Copyright © 1989 by American Roentgen Ray Society


Articles

MR findings in methotrexate-induced CNS abnormalities

F Ebner, G Ranner, I Slavc, C Urban, R Kleinert, H Radner, R Einspieler, and E Justich

Department of Radiology, Karl-Franzens-University Graz, Medical School, Austria.

MR of the brain was performed in eight patients (mean age, 14.9 years) with osteogenic sarcoma during or after IV treatment with high-dose methotrexate. MR detected brain abnormalities in four patients, three of whom had concomitant neurologic dysfunction. Pathologic findings demonstrated on MR were (1) chronic brain edema, demonstrable over a period of 3-14 months (proved by autopsy in one patient); (2) multifocal white matter necrosis; and (3) deep brain atrophy. MR appears to be valuable in the detection of abnormalities induced by treatment with high-dose methotrexate.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Neuro OncolHome page
A. F. Eichler, T. T. Batchelor, and J. W. Henson
Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate
Neuro-oncol, July 1, 2007; 9(3): 373 - 377.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. C.A. Steens, G. M. Steup-Beekman, G. P.Th. Bosma, F. Admiraal-Behloul, H. Olofsen, J. Doornbos, T. W.J. Huizinga, and M. A. van Buchem
The Effect of Corticosteroid Medication on Quantitative MR Parameters of the Brain
AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2475 - 2480.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S. Kitahara, S. Nakasu, K. Murata, K. Sho, and R. Ito
Evaluation of Treatment-Induced Cerebral White Matter Injury by Using Diffusion-Tensor MR Imaging: Initial Experience
AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2200 - 2206.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. Fliessbach, H. Urbach, C. Helmstaedter, H. Pels, A. Glasmacher, J. A. Kraus, T. Klockgether, I. Schmidt-Wolf, and U. Schlegel
Cognitive Performance and Magnetic Resonance Imaging Findings After High-Dose Systemic and Intraventricular Chemotherapy for Primary Central Nervous System Lymphoma
Arch Neurol, April 1, 2003; 60(4): 563 - 568.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Roentgen Ray Society.